menu
    • menu

    Company profile for IRBM

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a partner research organization with decades of experience in translating nascent research into drug discovery programs, providing support across the drug discovery pipeline, and offering stand-alone services to our partners. Since our establishment as the Italian site of Merck Research Laboratories in 2000, we have built an unprecedented track record in drug discovery. Our collaborative efforts have led to the succe...
    We are a partner research organization with decades of experience in translating nascent research into drug discovery programs, providing support across the drug discovery pipeline, and offering stand-alone services to our partners. Since our establishment as the Italian site of Merck Research Laboratories in 2000, we have built an unprecedented track record in drug discovery. Our collaborative efforts have led to the successful launch of four therapeutics currently on the market, and over 25 candidates in clinical trials. As a forward-looking organization grounded in global pharma heritage, high-level R&D expertise.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IRBMItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Via Pontina km 30,600 00071 Pomezia (RM)
    Telephone
    Telephone
    +39 06 91093692
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.irbm.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pipersandler/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IRBM Enhances Genomics Platform for Drug Discovery
    IRBM Enhances Genomics Platform for Drug Discovery

    03 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/irbm-expands-functional-genomics-platform-to-strengthen-early-drug-discovery-302418748.html

    PR NEWSWIRE
    03 Apr 2025
    Share Share
    ERS Genomics and IRBM Sign CRISPR/Cas9 License Agreement
    ERS Genomics and IRBM Sign CRISPR/Cas9 License Agreement

    20 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240520044085/en

    BUSINESSWIRE
    20 May 2024
    Share Share
    IRBM to Disclose Strong Antitumor Efficacy of Novel Preclinical Agents at AACR
    IRBM to Disclose Strong Antitumor Efficacy of Novel Preclinical Agents at AACR

    04 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/irbm-to-disclose-strong-antitumor-efficacy-of-novel-preclinical-agents-against-aggressive-brain-tumors-and-acute-lymphoblastic-leukemia-at-aacr-302108379.html

    PR NEWSWIRE
    04 Apr 2024
    Share Share
    IRBM Extends Peptide Therapeutics Collaboration with Merck & Co
    IRBM Extends Peptide Therapeutics Collaboration with Merck & Co

    22 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/22/2693327/0/en/IRBM-Extends-Peptide-Therapeutics-Collaboration-with-Merck-Co-Inc-Rahway-NJ-USA.html

    GLOBENEWSWIRE
    22 Jun 2023
    Share Share
    IRBM Selected for Participation in National Chemical Biology Consortium
    IRBM Selected for Participation in National Chemical Biology Consortium

    04 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/04/2640309/0/en/IRBM-Selected-for-Participation-in-National-Chemical-Biology-Consortium.html

    GLOBENEWSWIRE
    04 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search